Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
University Library
Adelaide Festival of Ideas
Barr Smith Press
Friends of the University of Adelaide Library
Library Publications
Internal documents (Library staff only)
Library images
Library reports and papers
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-6 of 6 (Search time: 0.003 seconds).
previous
1
next
Item hits:
Preview
Issue Date
Title
Author(s)
2013
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors
Rosen, L.
;
Lipton, L.
;
Price, T.
;
Belman, N.
;
Boccia, R.
;
Hurwitz, H.
;
Stephenson Jr, J.
;
Wirth, L.
;
McCoy, S.
;
Hei, Y.
;
Hsu, C.
;
Tebbutt, N.
2013
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML
Branford, S.
;
Yeung, D.
;
Ross, D.
;
Prime, J.
;
Field, C.
;
Altamura, H.
;
Yeoman, A.
;
Georgievski, J.
;
Jamison, B.
;
Phillis, S.
;
Sullivan, B.
;
Briggs, N.
;
Hertzberg, M.
;
Seymour, J.
;
Reynolds, J.
;
Hughes, T.
2013
Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation
Pettengell, R.
;
Schmitz, N.
;
Gisselbrecht, C.
;
Smith, G.
;
Patton, W.
;
Metzner, B.
;
Caballero, D.
;
Tilly, H.
;
Walewski, J.
;
Bence-Bruckler, I.
;
To, L.
;
Geisler, C.
;
Schots, R.
;
Kimby, E.
;
Taverna, C.
;
Kozak, T.
;
Dreger, P.
;
Uddin, R.
;
Ruiz de Elvira, C.
;
Goldstone, A.
2013
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy
Angelini, S.
;
Soverini, S.
;
Ravegnini, G.
;
Barnett, M.
;
Turrini, E.
;
Thornquist, M.
;
Pane, F.
;
Hughes, T.
;
White, D.
;
Radich, J.
;
Kim, D.
;
Saglio, G.
;
Cilloni, D.
;
Iacobucci, I.
;
Perini, G.
;
Woodman, R.
;
Cantelli-Forti, G.
;
Baccarani, M.
;
Hrelia, P.
;
Martinelli, G.
2013
Prospective histomorphometric and DXA evaluation of bone remodeling in imatinib-treated CML patients: Evidence for site-specific skeletal effects
Vandyke, K.
;
Fitter, S.
;
Drew, J.
;
Fukumoto, S.
;
Schultz, C.
;
Sims, N.
;
Yeung, D.
;
Hughes, T.
;
Zannettino, A.
2013
A no-prophylaxis platelet-transfusion strategy for hematologic cancers
Stanworth, S.
;
Estcourt, L.
;
Powter, G.
;
Kahan, B.
;
Dyer, C.
;
Choo, L.
;
Bakrania, L.
;
Llewelyn, C.
;
Littlewood, T.
;
Soutar, R.
;
Norfolk, D.
;
Copplestone, A.
;
Smith, N.
;
Kerr, P.
;
Jones, G.
;
Raj, K.
;
Westerman, D.
;
Szer, J.
;
Jackson, N.
;
Bardy, P.
;
et al.
Discover
Author
3
Hughes, T.
2
Yeung, D.
1
Altamura, H.
1
Angelini, S.
1
Baccarani, M.
1
Bakrania, L.
1
Bardy, P.
1
Barnett, M.
1
Belman, N.
1
Bence-Bruckler, I.
.
next >
Subject
6
Humans
5
Female
5
Middle Aged
3
Benzamides
3
Imatinib Mesylate
3
Leukemia, Myelogenous, Chronic, B...
3
Piperazines
3
Pyrimidines
2
Aged, 80 and over
2
Protein Kinase Inhibitors
.
next >